Zhejiang Hisun Pharma will raise at least 2 billion RMB ($328 million) in a private placement. The company will offer up to 139.5 million new shares at a price not lower than 14.26 RMB per share (current price is 17.22 RMB). Hisun will use the money to build facilities for three projects: facilities for solid preparations and injections, solid preparation cancer treatments and the Phase II of its biopharmaceutical initiative.
There are huge population of MMO game players in China. It's possible someday all the MMO games will be hosted in cloud, it will save players' hossile of downloading each game (which is easily over several GB in size) and improve graphic latency.
It's sold out again in a few minutes. People now can pre-order.
Mi3 looks very cool, better than iPhone5 IMO.
I saw it from Xiaomi's weibo (10/20). Here is the text from Xiaomi's co-founder Mr. Li:
Xiaomi said they will ramp up production to over 1 million mi3 phones per month from November.
It will be a super plus for Nvidia's GPU business. It will lock in the users to use Nvidia's GPU if they have a G-sync powered monitor.
Sohu just needs to show one quarter with good earning, and its SP will pass through all time high. The last time when it hit $105, its revenue was less than $200m, now is almost doubled.
I watched SSRX's BO process. management raised BO price about 10% before the vote date. Just wondering who would buy YONG at current BO offer. making 5% for the next 3 to 4 months doesn't sound very attactive.
You should blame the market for not giving the company fair market value. I saw many similar cases with US companies going private by leveraging the inefficiency of the stock market.
I think once P-Value comes down to 0.01, CLSN can claim statistically significant. From the trend, probably in one or two quarters?